Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Oculus Innovative Sciences, Inc. — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

121 daysmedian FDA review time
365 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K102945PEDIACYN ATOPIC DERMATITIS HYDROGELOculus Innovative Sciences, Inc.2011-02-021210
K093585MICROCYN SKIN AND WOUND HYDROGELOculus Innovative Sciences, Inc.2010-03-081091
K090206OCULUS PURACYN ANTIMICROBIAL SKIN AND WOUND CLEANSEROculus Innovative Sciences, Inc.2009-06-021253
K090725OCULUS MICROCYN WOUND GELOculus Innovative Sciences, Inc.2009-05-20620
K060113DERMACYN WOUND CAREOculus Innovative Sciences, Inc.2006-02-22360
K042729DERMACYN WOUND IRRIGATIONOculus Innovative Sciences, Inc.2005-05-172280
K041161MICROCYN WOUND CARE DRESSINGOculus Innovative Sciences, Inc.2005-05-033652

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda